Comparison of operation related complexity and outcomes of percutaneous nephrolithotomy between complete supine position and semi-supine position

Comparison of operation related complexity and outcomes of percutaneous nephrolithotomy between complete supine position and semi-supine position in hospitalised patients with upper urinary tract stones

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201405041853N10

Enrollment

Registered

2014-06-17

Start date

2012-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis. Calculus of kidney

Interventions

Intervention 1: Complete Supine Percutaneous Nephrolithotomy. Intervention 2: Semi-Supine Percutaneous Nephrolithotomy.

Treatment - Surgery

Complete Supine Percutaneous Nephrolithotomy

Semi-Supine Percutaneous Nephrolithotomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: sign a consent form by the patient; patients at least 12 years of age; single or multiple stones in the upper urinary tract (calyx, the pelvis, upper ureter) with stone burden = 2 cm; lower calyx stones with stone burden = 1.5 cm; ESWL-resistant stones = 1 cm; Exclusion criteria: those with uncontrolled coagulopathy; pregnancy; history of immunosuppression; renal anomalies and untreated positive UTI (urinary tract infection); upper urinary tract stones with the stone burden = 2 cm; lower calyx stones with stone burden =1 cm; complete staghorn stone

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Overlapping with the spine at the angle of 30° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Overlapping with the spine at the angle of 0° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Overlapping with the edge of the bed at the angle of 0° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Overlapping with the edge of the bed at the angle of 30° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Fluoroscopic Screening Time. Timepoint: intraoperative. Method of measurement: Timer.;Access time. Timepoint: intraoperative. Method of measurement: Timer.;Kidney displacement with 18 gauge needle. Timepoint: intraoperative. Method of measurement: Dial on fluoroscopy.;Kidney displacement with 9Fr amplatz dilator. Timepoint: intraoperative. Method of measurement: Dial on fluoroscopy.;Kidney displacement 28Fr amplatz dilator. Timepoint: intraoperative. Method of measurement: Dial on fluoroscopy.	—

Measure

Time frame

Overlapping with the spine at the angle of 30° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Overlapping with the spine at the angle of 0° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Overlapping with the edge of the bed at the angle of 0° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Overlapping with the edge of the bed at the angle of 30° flouroscopy. Timepoint: intraoperative. Method of measurement: flouroscop.;Fluoroscopic Screening Time. Timepoint: intraoperative. Method of measurement: Timer.;Access time. Timepoint: intraoperative. Method of measurement: Timer.;Kidney displacement with 18 gauge needle. Timepoint: intraoperative. Method of measurement: Dial on fluoroscopy.;Kidney displacement with 9Fr amplatz dilator. Timepoint: intraoperative. Method of measurement: Dial on fluoroscopy.;Kidney displacement 28Fr amplatz dilator. Timepoint: intraoperative. Method of measurement: Dial on fluoroscopy.

—

Secondary

Measure	Time frame
Operation time. Timepoint: postoperative. Method of measurement: Timer.;Postoperative Hospital stay. Timepoint: postoperative. Method of measurement: Day.;Stone free rate. Timepoint: postoperative. Method of measurement: KUB.;Hb drop. Timepoint: postoperative. Method of measurement: Blood test.;Blood transfusion. Timepoint: postoperative. Method of measurement: Blood test.;Complication. Timepoint: postoperative. Method of measurement: Blood test, Physical examination.	—

Measure

Time frame

Operation time. Timepoint: postoperative. Method of measurement: Timer.;Postoperative Hospital stay. Timepoint: postoperative. Method of measurement: Day.;Stone free rate. Timepoint: postoperative. Method of measurement: KUB.;Hb drop. Timepoint: postoperative. Method of measurement: Blood test.;Blood transfusion. Timepoint: postoperative. Method of measurement: Blood test.;Complication. Timepoint: postoperative. Method of measurement: Blood test, Physical examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Ghasemi

Urology Research Center

urc1384@yahoo.com+98 13 1552 5259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026